Infectious Bursal Disease, Newcastle Disease & Reo Virus Vaccine, Inactivated, Standard Type 1, LaSota, S1133 & 1733 strains

For Breeder Hens

This vaccine has been developed for use in breeder hens and replacement pullets to give broad protection against Newcastle disease and to provide maternal antibodies for the early protection of progeny against Reovirus related malabsorption syndrome and tenosynovitis and against Type 1, Infectious Bursal disease (Gumboro disease), standard strain. When injected, the vaccine produces a high level of circulating antibody (humoral immunity), which is maintained throughout the production cycle. This provides high levels of parental immunity in the progeny. This is the only way to provide protection to the chick during the critical first few days of life. Early infection with IBD (Gumboro disease) causes permanent damage to the immune system and leaves the flock susceptible to many other diseases. Early infection with Reovirus is responsible for tenosynovitis and malabsorption syndrome with all of its various disease conditions (pale bird syndrome, femoral head necrosis, stunting disease, helicopter disease, etc.).

It is produced with a high tittering strain of Newcastle disease virus and contains two Reovirus strains: the S1 133 strain (a tenosynovitis pathotype) and the 1733 strain (a malabsorption syndrome pathotype). It also contains one IBD strains: the standard Type 1 strain. By using virus concentration, large amounts of all antigens are provided in a 1/2 ml dose. When injected, the oil emulsion controls the absorption of the virus and greatly enhances the development of high levels of immunity. The product meets rigid 'Quality Control' standards of Purity, Safety and Potency as per individual monographs of viral vaccines of B.P. (Vet).

Each dose contains not less than a pre-inactivation titer of 1 x 109 EID50 Newcastle disease virus, 1 x 106.2 TCID50 Infectious Bursal disease virus and 1 x 105.8 TCID50 1733 & 1 x 106.3 TCID50 S1133 strains.

It is completely safe because it contains no living virus. This killed virus vaccine in oil emulsion provides more consistent high titers throughout the production period than the live virus vaccines. The ND viruses are contagious and can recycle within the flock. This can cause loss of egg production without symptoms. It protects the reproductive system against homologous strains and prevents such egg losses. It can be safely administered at any age. Immunity is delivered to the farm with the chicks.

Dosage & Administration
Birds should be "primed" with live virus vaccines for Newcastle disease at 10 to 14 days and at 12 weeks of age. Prime with attenuated live virus tenosynovitis vaccine at 7 days and at 12 weeks of age. Prime with mild or intermediate strain of live virus IBD vaccine at 21 days and 12 weeks of age. Vaccinate with this vaccine between 16 and 20 weeks of age. If birds are held for a second year, revaccinate during molt. Dosage is 1/2 ml (0.5 ml) per bird. Vaccine should be brought to room temperature before use. Inject subcutaneously in the lower neck region using aseptic technique. Inject all birds in the flock.

Warning: Do not vaccinate within 42 days before slaughter.

The capability of this vaccine to produce satisfactory results depends upon many factors, including - but not limited to - conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual chickens, and degree of field exposure. Therefore, directions for use should be followed carefully.

  • Do not use chemical disinfectants for sterilization
  • Remove the vaccine from refrigerator at least 1 day before vaccination for better results
  • Use entire contents
  • Shake well before and during use
  • Vaccinate only healthy birds
  • Use entire contents of bottle when first opened
  • For veterinary use only

Packaging & Storage
It is available in 500 ml polypropylene bottles. Each contains 1000 doses of vaccine, packed 18 bottles per case.
Store between 2°C and 8°C. Do not freeze.Protect from light.